MacroGenics, Inc.

MGNX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Oct 23, 2026 8-K
144 Oct 22, 2026
4 Oct 7, 2026 FORM 4
144 Sep 21, 2026
S-8 Sep 3, 2026 S-8
8-K/A Sep 3, 2026 8-K/A
4 Aug 20, 2026 FORM 4
144 Aug 19, 2026
4 Aug 18, 2026 FORM 4
144 Aug 17, 2026
10-Q Aug 14, 2026 10-Q
SCHEDULE 13G/A Aug 14, 2026
8-K Aug 13, 2026 8-K
144 Aug 3, 2026
SCHEDULE 13G/A Aug 3, 2026
SCHEDULE 13G Jul 29, 2026
8-K Jul 23, 2026 8-K
SCHEDULE 13G/A Jul 20, 2026
144 Jul 13, 2026
8-K Jul 8, 2026 8-K
8-K Jul 7, 2026 8-K
SCHEDULE 13G Jun 5, 2026
4 May 20, 2026 FORM 4
4 May 20, 2026 FORM 4
4 May 20, 2026 FORM 4
← Newer Page 1 of 38 · 939 filings Older →